Literature DB >> 23169966

Influenza surveillance in Zambia, 2008-2009.

Andros Theo1, Mazyanga Liwewe, Idah Ndumba, Zacharia Mupila, Bushimbwa Tambatamba, Charles Mutemba, Somwe Wa Somwe, Alywn Mwinga, Stefano Tempia, Mwaka Monze.   

Abstract

BACKGROUND: Limited information exists about influenza viruses in Africa. We used data from a new sentinel surveillance system to investigate the seasonality and characteristics of influenza, including pandemic (pdm) influenza A H1N1, in Zambia.
METHODS: In June 2008, we established sentinel surveillance for influenza-like illness (ILI) and severe acute respiratory illness (SARI) at 4 healthcare facilities in Zambia. Nasopharyngeal and oropharyngeal swabs and structured questionnaires were collected from eligible patients and samples were tested by real-time reverse-transcription polymerase chain reaction for influenza virus types and subtypes.
RESULTS: From June 2008 to December 2009, we collected 1234 specimens, of which 334 (27%) were ILI, and 900 (63%) were SARI. Overall, 4% (57) of specimens were positive for influenza. The influenza detection rate in ILI and SARI cases was 5% (17/334) and 4% (40/900), respectively. Among all influenza cases, 54 (95%) were influenza A and 3 (5%) were influenza B. Of the influenza A viruses, 16 (30%) were A(H1N1)pdm09, 29 (54%) were seasonal A(H1N1), 6 (11%) were A(H3N2), and 4 (7%) were unsubtyped. The detection rate for A(H1N1)pdm09 cases was highest in persons aged 5-24 years (5/98; 5%), 25-44 years (4/78; 5%), and 45-64 years (1/17; 6%). Conversely, for seasonal influenza the detection rate was highest in children aged 1-4 years (18/294; 6%). Influenza virus circulation peaked during June-August in both years and A(H1N1)pdm09 occurred at the end of the influenza season in 2009.
CONCLUSIONS: Seasonal influenza virus infection was found to be associated with both mild and severe respiratory illness in Zambia. Future years of surveillance are necessary to better define the seasonality and epidemiology of influenza in the country.

Entities:  

Mesh:

Year:  2012        PMID: 23169966     DOI: 10.1093/infdis/jis599

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Identification of viral and bacterial pathogens from hospitalized children with severe acute respiratory illness in Lusaka, Zambia, 2011-2012: a cross-sectional study.

Authors:  Paul Simusika; Allen C Bateman; Andros Theo; Geoffrey Kwenda; Christine Mfula; Edward Chentulo; Mwaka Monze
Journal:  BMC Infect Dis       Date:  2015-02-12       Impact factor: 3.090

2.  Clinical and epidemiological characterization of influenza virus infections in children with severe acute respiratory infection in Maputo, Mozambique: Results from the implementation of sentinel surveillance, 2014 - 2016.

Authors:  Neuza Nguenha; Almiro Tivane; Mirela Pale; Loira Machalele; Afonso Nacoto; Germano Pires; Edirsse Mationane; Judite Salência; Félix Gundane; Délcio Muteto; Josina Chilundo; Sandra Mavale; Noorbebi Adamo; Cynthia Semá-Baltazar; Orvalho Augusto; Eduardo Gudo; Tufária Mussá
Journal:  PLoS One       Date:  2018-03-28       Impact factor: 3.240

Review 3.  Viral pneumonia in adults and older children in sub-Saharan Africa - epidemiology, aetiology, diagnosis and management.

Authors:  Antonia Ho
Journal:  Pneumonia (Nathan)       Date:  2014-12-01

4.  Epidemiology of circulating human influenza viruses from the Democratic Republic of Congo, 2015.

Authors:  Hugo Kavunga-Membo; Edith Nkwembe; Edgar Simulundu; Stomy Karhemere; Pélagie Babakazo; Léonie Manya; Joelle Kabamba; Emile Okitolonda; Steve Ahuka-Mundeke; Jean Jacques Muyembe
Journal:  PLoS One       Date:  2018-09-28       Impact factor: 3.240

5.  Declines in Pneumonia and Meningitis Hospitalizations in Children Under 5 Years of Age After Introduction of 10-Valent Pneumococcal Conjugate Vaccine in Zambia, 2010-2016.

Authors:  Evans M Mpabalwani; Chileshe Lukwesa-Musyani; Akakambama Imamba; Ruth Nakazwe; Belem Matapo; Chilweza M Muzongwe; Trust Mufune; Elizabeth Soda; Jason M Mwenda; Chelsea S Lutz; Tracy Pondo; Fernanda C Lessa
Journal:  Clin Infect Dis       Date:  2019-09-05       Impact factor: 9.079

6.  An evaluation of the Zambia influenza sentinel surveillance system, 2011-2017.

Authors:  Paul Simusika; Stefano Tempia; Edward Chentulo; Lauren Polansky; Mazyanga Lucy Mazaba; Idah Ndumba; Quinn K Mbewe; Mwaka Monze
Journal:  BMC Health Serv Res       Date:  2020-01-13       Impact factor: 2.655

7.  First COVID-19 case in Zambia - Comparative phylogenomic analyses of SARS-CoV-2 detected in African countries.

Authors:  Edgar Simulundu; Francis Mupeta; Pascalina Chanda-Kapata; Ngonda Saasa; Katendi Changula; Walter Muleya; Simbarashe Chitanga; Miniva Mwanza; Paul Simusika; Herman Chambaro; Benjamin Mubemba; Masahiro Kajihara; Duncan Chanda; Lloyd Mulenga; Sombo Fwoloshi; Aaron Lunda Shibemba; Fred Kapaya; Paul Zulu; Kunda Musonda; Mwaka Monze; Nyambe Sinyange; Mazyanga L Mazaba; Muzala Kapin'a; Peter J Chipimo; Raymond Hamoonga; Davie Simwaba; William Ngosa; Albertina N Morales; Nkomba Kayeyi; John Tembo; Mathew Bates; Yasuko Orba; Hirofumi Sawa; Ayato Takada; King S Nalubamba; Kennedy Malama; Victor Mukonka; Alimuddin Zumla; Nathan Kapata
Journal:  Int J Infect Dis       Date:  2020-10-06       Impact factor: 3.623

8.  Influenza vaccines and influenza antiviral drugs in Africa: are they available and do guidelines for their use exist?

Authors:  Jazmin Duque; Meredith L McMorrow; Adam L Cohen
Journal:  BMC Public Health       Date:  2014-01-16       Impact factor: 3.295

9.  Global dynamic spatiotemporal pattern of seasonal influenza since 2009 influenza pandemic.

Authors:  Zhi-Wei Xu; Zhong-Jie Li; Wen-Biao Hu
Journal:  Infect Dis Poverty       Date:  2020-01-03       Impact factor: 4.520

10.  The national burden of influenza-associated severe acute respiratory illness hospitalization in Zambia, 2011-2014.

Authors:  Andros Theo; Stefano Tempia; Adam L Cohen; Paul Simusika; Edward Chentulo; Chikama Mukwangole Chikamukwa; Mwaka Monze
Journal:  Influenza Other Respir Viruses       Date:  2017-12-15       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.